@article{c53bab62b3f4467c84afaa022ab81cbd,
title = "SCAI expert consensus statement on operator and institutional requirements for PFO closure for secondary prevention of paradoxical embolic stroke: The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists.",
abstract = "Until recently, evidence to support Patent Foramen Ovale (PFO) closure for secondary prevention of recurrent stroke has been controversial. Publication of high-quality evidence from randomized clinical trials and the subsequent FDA approval of two devices for percutaneous PFO closure is expected to increase the volume of PFO closure procedures not only in the United States but worldwide. As this technology is disseminated broadly to the public, ensuring the safe and efficacious performance of PFO closure is essential to mitigate risk and avoid unnecessary procedures. This document, prepared by a multi-disciplinary writing group convened by the Society for Cardiovascular Angiography and Interventions and including representatives from the American Academy of Neurology, makes recommendations for institutional infrastructure and individual skills necessary to initiate and maintain an active PFO/stroke program, with emphasis on shared decision making and patient-centered care.",
keywords = "ASD/PDA/PFO, closure, comparative effectiveness/patient centered outcomes research, evidence-based medicine, structural heart disease intervention",
author = "Eric Horlick and Kavinsky, {Clifford J.} and Zahid Amin and {Dean Boudoulas}, Konstantinos and Carroll, {John D.} and Hijazi, {Ziyad M.} and Dana Leifer and Lutsep, {Helmi L.} and Rhodes, {John F.} and Tobis, {Jonathan M.}",
note = "Funding Information: In accordance with SCAI policies on relationships with industry and other entities (RWI), relevant author disclosures are included in Supporting Information Table S1. To avoid actual, potential, or perceived conflicts of interest because of industry relationships or other personal conflicts, members of the writing committee and the peer reviewers of this document were asked to disclose all present or prior (within 12 months before the initiation of this clinical document) potential conflicts. The writing committee includes a majority of members without relevant RWI. Authors with relevant RWI were not permitted to draft or vote on content or recommendations pertaining to their RWI. RWI were reviewed during conference calls and updated as changes occurred. The work of the writing committee was supported exclusively by SCAI without commercial support. Writing committee members donated their time for the preparation of this document. Conference calls of the writing committee were closed and attended only by committee members and society staff. The respective executive boards of the two professional societies provided final review and approval of the document.",
year = "2019",
month = apr,
day = "1",
doi = "10.1002/ccd.28111",
language = "English (US)",
volume = "93",
pages = "859--874",
journal = "Catheterization and Cardiovascular Interventions",
issn = "1522-1946",
publisher = "Wiley-Liss Inc.",
number = "5",
}